GLP1R and obesity due to melanocortin 4 receptor deficiency: Similarly, the glucagon-like peptide-1 receptor (GLP-1R) is well established as a therapeutic target for type 2 diabetes and obesity, with GLP-1R agonists effectively lowering glucose levels and promoting weight loss.